Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?
Open Access
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (12), 1667-1670
- https://doi.org/10.1023/a:1013574413217
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cancer mortality in Europe, 1990–1994, and an overview of trends from 1955 to 1994European Journal Of Cancer, 1999
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Pre-treatment prognostic factors in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapyLung Cancer, 1995
- Chemotherapy vs Supportive Care in Advanced Non-Small-Cell Lung CancerChest, 1994
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaCancer, 1982
- Survival with inoperable lung cancer.An integration of prognostic variables based on simple clinical criteriaCancer, 1977